Video Experimental Relacionado
Updated: Jul 6, 2026
08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Enfermedad cardiovascular prematura en insuficiencia renal crónica
Lancet (London, England)
|August 30, 2000
Resumen
Los pacientes con enfermedad renal crónica se enfrentan a altos riesgos de enfermedad cardiovascular (ECV). Se necesitan grandes ensayos para probar tratamientos como medicamentos para reducir el colesterol y antihipertensivos para reducir este riesgo.
Área de la Ciencia:
- Nefrología Nefrología.
- Cardiología Cardiología.
- Los ensayos clínicos son ensayos clínicos.
Sus antecedentes:
- Los pacientes con insuficiencia renal crónica (IFC) tienen un alto riesgo de enfermedad cardiovascular (ECV).
- Falta información confiable sobre los determinantes del riesgo de ECV en pacientes con FCR.
- Los pacientes con FRC a menudo se excluyen de los ensayos clínicos debido a preocupaciones de seguridad.
Objetivo del estudio:
- Para resaltar la necesidad de más investigación sobre el riesgo de ECV en pacientes con insuficiencia renal crónica.
- Abogar por ensayos aleatorizados a gran escala para evaluar las intervenciones para la ECV en pacientes renales.
- Para enfatizar el potencial de beneficios significativos del tratamiento de ECV en esta población.
Principales métodos:
- El resumen discute la necesidad de ensayos aleatorizados a gran escala.
- Sugiere investigar intervenciones tales como medicamentos para bajar el colesterol, antihipertensivos, aspirina, vitaminas B y vitaminas antioxidantes.
- Se pide una mayor investigación sobre los mecanismos subyacentes de la enfermedad cardíaca en la FRC.
Principales resultados:
- El riesgo absoluto de ECV en pacientes con FRC es sustancial.
- Los potenciales beneficios absolutos de los tratamientos pueden compensar el aumento de los riesgos.
- Los tratamientos efectivos identificados e iniciados a tiempo podrían disminuir el riesgo de ECV.
Conclusiones:
- Existe una necesidad crítica de más investigación y ensayos aleatorizados a gran escala para abordar la ECV en la insuficiencia renal crónica.
- Investigar intervenciones como los medicamentos para reducir los lípidos y los antihipertensivos es crucial.
- El tratamiento temprano y seguro de las ECV en pacientes renales puede reducir significativamente la morbilidad y la mortalidad.
Más Videos Relacionados
07:41A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats
Published on: March 1, 2022
07:49A Pacing-Controlled Procedure for the Assessment of Heart Rate-Dependent Diastolic Functions in Murine Heart Failure Models
Published on: July 21, 2023
Videos de Conceptos Relacionados
01:26Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
01:20Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:30Peripheral Artery Disease I: Introduction
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...